Atlas Trials

Precigen, Inc

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Precigen, Inc

RecordFirmDate
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer (NCT06157151)Precigen, Inc2025-11-11
Zopa Retreatment and Vector Shedding in Adults With RRP (NCT06538480)Precigen, Inc2024-07-11
Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis (NCT04724980)Precigen, Inc2021-03-16
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS (NCT03927261)Precigen, Inc2019-05-20
Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT03907527)Precigen, Inc2019-04-30

Track Precigen, Inc automatically

Every clearance here is in the API, with alerts when new ones post.